Abstract:Three novel structural series of 4 ''-O-(1-aralkyl-1,2,3-triazol-4-methyl-carbamoyl) azithromycin analogs were designed, synthesized and evaluated for their in vitro antibacterial activity. All the target compounds exhibited excellent activity against erythromycin-susceptible Streptococcus pyogenes, and significantly improved activity against three phenotypes of erythromycin-resistant Streptococcus pneumoniae compared with clarithromycin and azithromycin. Among the three series of azithromycin analogs, the novel series of 11,4 ''-disubstituted azithromycin analogs 9a-k exhibited the most effective and balanced activity against susceptible and resistant bacteria. Among them, compound 9j showed the most potent activity against Staphylococcus aureus ATCC25923 (0.008 Kg/mL) and Streptococcus pyogenes R2 (1 mu g/mL). Besides, all the 11,4 ''-disubstituted azithromycin analogs 9a-k except 9f shared the identical activity with the MIC value <0.002 mu g/mL against Streptococcus pyogenes S2. Furthermore, compounds 9g, 9h, 9j and 9k displayed significantly improved activity compared with the references against all the three phenotypes of resistant S. pneumoniae. Particularly, compound 9k was the most effective (0.06, 0.03 and 0.125 mu g/mL) against all the erythromycin-resistant S. pneumoniae expressing the erm gene, the mef gene and the erm and mef genes, exhibiting 2133, 133 and 2048-fold more potent activity than azithromycin, respectively. (C) 2017 Elsevier Ltd. All rights reserved.

Synthesis and antibacterial activity of 4″-O-carbamoyl analogs of clarithromycin

Novel Clarithromycin Analogs with C-4&#x201D; 2-Arylbenzimidazolyl Bishydrazide Side Chain: Synthesis and Antibacterial Evaluation

Synthesis and antibacterial activity of novel 4''-O-arylalkylcarbamoyl and 4''-O-((arylalkylamino)-4-oxo-butyl)carbamoyl clarithromycin derivatives.

Synthesis and antibacterial activity of novel 4″-O-benzimidazolyl clarithromycin derivatives.

Synthesis and Antibacterial Activity of Novel 4"-O-carbamoyl Erythromycin-A Derivatives

Synthesis and Antibacterial Evaluation of Novel 11-O-carbamoyl Clarithromycin Ketolides

Synthesis and Antibacterial Activity of Novel 3-O-carbamoyl Derivatives of Clarithromycin and 11,12-Cyclic Carbonate Azithromycin

Synthesis and Antibacterial Activity of New 4″-O-carbamates of 11,12-Cyclic Carbonate Erythromycin A 6,9-Imino Ether

Synthesis and Antibacterial Evaluation of Novel Clarithromycin Derivatives with C-4″ Elongated Arylalkyl Groups Against Macrolide-Resistant Strains.

Synthesis and Antibacterial Activity of Novel 15-Membered Macrolide Derivatives: 4″-Carbamate, 11,12-Cyclic Carbonate-4″-carbamate and 11,4″-Di-o-arylcarbamoyl Analogs of Azithromycin

Synthesis and Antibacterial Activity of Novel 3-O-arylalkylcarbamoyl-3-o-descladinosyl-9-o-(2-chlorobenzyl)oxime Clarithromycin Derivatives

Synthesis and antibacterial activity of novel 4|[Prime]|-carbamates of 6,11-di-O-methylerythromycin A

Synthesis and Antibacterial Activity of 4″,11-Di-o-arylalkylcarbamoyl Azithromycin Derivatives

Synthesis and Antibacterial Evaluation of Novel 11-O-aralkylcarbamoyl-3-o-descladinosylclarithromycin Derivatives

Synthesis and antibacterial activity of 4″- O -(trans- β -arylacrylamido)carbamoyl azithromycin analogs

Synthesis and Antibacterial Activity of Novel 4″-O-(1-aralkyl-1,2,3-triazol-4-methyl-carbamoyl) Azithromycin Analogs.

Synthesis and antibacterial activity of 3-O-carbamoyl derivatives of 6,11-di-O-methylerythromycin A: a novel class of acylides.

Synthesis and Antibacterial Activity of Novel 11-O-phenethylcarbamoylazithromycin Derivatives with 4 ''-Elongated Side Chains

ChemInform Abstract: Synthesis and Antibacterial Activity of Novel 4′′‐carbamates of 6,11‐di‐o‐methylerythromycin A.

Synthesis and Antibacterial Evaluation of Novel 11,4″-Disubstituted Azithromycin Analogs with Greatly Improved Activity Against Erythromycin-Resistant Bacteria.

Novel C-4″ Modified Azithromycin Analogs with Remarkably Enhanced Activity Against Erythromycin-Resistant Streptococcus Pneumoniae: the Synthesis and Antimicrobial Evaluation